Quick Answer
HeartBeam, Inc. reported Net Income of -$21.02 million for fiscal year 2025.
HeartBeam, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net Income | -$21.02M -8.1% |
-$19.45M -32.9% |
-$14.64M -12.9% |
-$12.96M -192.7% |
-$4.43M -314.6% |
-$1.07M |
| Diluted EPS | -$0.62 +15.1% |
-$0.73 -1.4% |
-$0.72 +54.7% |
-$1.59 -54.4% |
-$1.03 -255.2% |
-$0.29 |
| Total Assets | $5.84M +78.4% |
$3.28M -80.9% |
$17.13M +324.1% |
$4.04M -71.1% |
$14.00M +27347.1% |
$51.0K |
| Cash and Equivalents | $4.38M +84.3% |
$2.38M -85.3% |
$16.19M +350.4% |
$3.59M -72.8% |
$13.19M | — |
| Stockholders Equity | $2.60M +57.4% |
$1.65M -89.6% |
$15.94M +571.3% |
$2.37M -82.3% |
$13.41M +380.3% |
-$4.79M -28.4% |
| R&D Expense | $13.45M +21.7% |
$11.05M +62.6% |
$6.80M +19.7% |
$5.68M +2126.3% |
$255.0K +91.7% |
$133.0K |
| Operating Income | -$21.14M -6.3% |
-$19.89M -29.9% |
-$15.31M -17.5% |
-$13.03M -470.3% |
-$2.29M -190.0% |
-$788.0K |
| Shares Outstanding | 26.96M +0.0% |
26.96M +2.4% |
26.33M +228.7% |
8.01M +2.6% |
7.81M +121.4% |
3.53M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$5.25M | -5.5% | -5.6% |
| Diluted EPS | September 30, 2025 | -$0.15 | +21.1% | +0.0% |
| Total Assets | September 30, 2025 | $2.88M | -56.8% | -51.9% |
| Cash and Equivalents | September 30, 2025 | $1.86M | -67.8% | -43.0% |
| Stockholders Equity | September 30, 2025 | $406.0K | -91.5% | -90.3% |
| R&D Expense | September 30, 2025 | $3.28M | +13.3% | -1.4% |
| Operating Income | September 30, 2025 | -$5.29M | -4.4% | -5.0% |
| Shares Outstanding | September 30, 2025 | 34.34M | +29.1% | +0.9% |
- HeartBeam, Inc. reported Net Income of -$21.02 million for fiscal year 2025.
- HeartBeam, Inc. showed a decrease of -8.1% in Net Income compared to the prior fiscal year.
- HeartBeam, Inc. reported Diluted EPS of $0.62 per share (loss) for fiscal year 2025.
- HeartBeam, Inc. showed an increase of +15.1% in Diluted EPS compared to the prior fiscal year.
- HeartBeam, Inc. reported Total Assets of $5.84 million for fiscal year 2025.
- HeartBeam, Inc. showed an increase of +78.4% in Total Assets compared to the prior fiscal year.
- HeartBeam, Inc. reported Cash and Equivalents of $4.38 million for fiscal year 2025.
- HeartBeam, Inc. showed an increase of +84.3% in Cash and Equivalents compared to the prior fiscal year.
- HeartBeam, Inc. reported Stockholders Equity of $2.60 million for fiscal year 2025.
- HeartBeam, Inc. showed an increase of +57.4% in Stockholders Equity compared to the prior fiscal year.
- HeartBeam, Inc. reported R&D Expense of $13.45 million for fiscal year 2025.
- HeartBeam, Inc. showed an increase of +21.7% in R&D Expense compared to the prior fiscal year.
- HeartBeam, Inc. reported Operating Income of -$21.14 million for fiscal year 2025.
- HeartBeam, Inc. showed a decrease of -6.3% in Operating Income compared to the prior fiscal year.
- HeartBeam, Inc. reported Shares Outstanding of 26.96 million shares for fiscal year 2025.
- HeartBeam, Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: